Justin A Renz
CIK 1466562 · CFO · last filed 2026-03-19
Justin A Renz is a CFO who has filed 47 SEC Form 4 insider transactions across 4 companies since 2009. The most recent filing, for ZVRA, was dated Mar 19, 2026. Across all open-market trades the lifetime net is −$1.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.55M
4
47
-$1.69M
Filer Profile
85 WELLS AVENUE, SECOND FLOOR
NEWTON, MA 02459
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ZVRA | CFO | — | $12.40 | — | $0 | 1 | 2026-03-19 |
| ARDX | Chief Financial Officer | 409,052 | $3.78 | $1.55M | -$1.80M | 30 | 2025-08-25 |
| KPTI | EVP, CFO & Treasurer | 1,278 | $1.79 | $2.3K | $113.0K | 8 | 2017-01-24 |
| EPIRUS Biopharmaceuticals, Inc. (CRXX) Delisted | SVP & CFO | — | — | — | $0 | 2 | 2010-01-20 |
Recent Filings
47 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-19 | ZVRA | Grant (A) | — | $0 | EDGAR |
| 2025-11-24 | ARDX | Notice (144) | −49,040 | -$272.2K | EDGAR |
| 2025-08-25 | ARDX | Sell (S) | −7,037 | -$41.7K | EDGAR |
| 2025-05-22 | ARDX | Sell (S) | −7,218 | -$29.5K | EDGAR |
| 2025-02-27 | ARDX | Grant (A) | +136,680 | $0 | EDGAR |
| 2025-02-21 | ARDX | Sell (S) | −5,171 | -$29.1K | EDGAR |
| 2024-11-22 | ARDX | Sell (S) | −5,260 | -$25.2K | EDGAR |
| 2024-08-22 | ARDX | Sell (S) | −5,289 | -$31.0K | EDGAR |
| 2024-05-23 | ARDX | Sell (S) | −5,167 | -$40.4K | EDGAR |
| 2024-02-22 | ARDX | Sell (S) | −5,341 | -$46.7K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.